Literature DB >> 10549859

Slow wave sleep-inducing effects of first generation H1-antagonists.

K Saitou1, Y Kaneko, Y Sugimoto, Z Chen, C Kamei.   

Abstract

The present study was performed to see if first-generation histamine H1-antagonists are useful sedative-hypnotic drugs. Increases in electroencephalogram (EEG) power spectra of the delta band (0-4 Hz) at the frontal cortex and theta band (4-8 Hz) at the hippocampus in rats were used as an indexes of sleep. The H1-antagonists used in this study resulted in a decrease in sleep latency and an increase in sleep duration (slow wave sleep). The rate of REM (rapid eye movement) sleep during slow wave sleep was decreased by H1-antagonists and brotizolam. The order of potency of H1-antagonists for the reduction in sleep latency (from greatest to least) was promethazine>chlorpheniramine>diphenhydramine and pyrilamine, and that for the increase in sleep duration was chlorpheniramine>promethazine>diphenhydramine and pyrilamine. Brotizolam was more potent than these H1-antagonists, with 14-18-fold and 4-14-fold greater effects on sleep latency and duration, respectively. These results clearly show that H1-antagonists are effective in mild to moderate insomnia as sedative-hypnotic drugs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10549859     DOI: 10.1248/bpb.22.1079

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  10 in total

1.  The effect of agomelatine on 5HT(2C) receptors in humans: a clinically relevant mechanism?

Authors:  Trevor R Norman
Journal:  Psychopharmacology (Berl)       Date:  2012-02-15       Impact factor: 4.530

Review 2.  [Hypnotics--state of the science].

Authors:  C Nissen; L Frase; G Hajak; T C Wetter
Journal:  Nervenarzt       Date:  2014-01       Impact factor: 1.214

3.  Induction of prolonged, continuous slow-wave sleep by blocking cerebral H₁ histamine receptors in rats.

Authors:  Masami Ikeda-Sagara; Tomoya Ozaki; Mohammad Shahid; Eri Morioka; Kazuma Wada; Kazuki Honda; Ayana Hori; Yuji Matsuya; Naoki Toyooka; Masayuki Ikeda
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

4.  Effects of three hypnotics on the sleep-wakefulness cycle in sleep-disturbed rats.

Authors:  Kazuaki Shinomiya; Yuki Shigemoto; Junji Omichi; Yoshiaki Utsu; Mitsunobu Mio; Chiaki Kamei
Journal:  Psychopharmacology (Berl)       Date:  2004-01-14       Impact factor: 4.530

5.  Differential effects of acute and repeat dosing with the H3 antagonist GSK189254 on the sleep-wake cycle and narcoleptic episodes in Ox-/- mice.

Authors:  R X Guo; C Anaclet; J C Roberts; R Parmentier; M Zhang; G Guidon; C Buda; J P Sastre; J Q Feng; P Franco; S H Brown; N Upton; A D Medhurst; J S Lin
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

6.  FASTER: an unsupervised fully automated sleep staging method for mice.

Authors:  Genshiro A Sunagawa; Hiroyoshi Séi; Shigeki Shimba; Yoshihiro Urade; Hiroki R Ueda
Journal:  Genes Cells       Date:  2013-04-28       Impact factor: 1.891

Review 7.  Orexin receptor antagonists as therapeutic agents for insomnia.

Authors:  Ana C Equihua; Alberto K De La Herrán-Arita; Rene Drucker-Colin
Journal:  Front Pharmacol       Date:  2013-12-25       Impact factor: 5.810

8.  A Standardized Phlorotannin Supplement Attenuates Caffeine-Induced Sleep Disruption in Mice.

Authors:  Sangoh Kwon; Minseok Yoon; Jaekwang Lee; Kwang-Deog Moon; Dohyeon Kim; Seon-Bong Kim; Suengmok Cho
Journal:  Nutrients       Date:  2019-03-06       Impact factor: 5.717

9.  The efficacy study on si ni san freeze-dried powder on sleep phase in insomniac and normal rats.

Authors:  Yuefeng Li; Angguo Liu; Ying Wang; Xingke Yan
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-30       Impact factor: 2.629

10.  Pathobiology of Second-Generation Antihistamines Related to Sleep in Urticaria Patients.

Authors:  Caroline Mann; Joanna Wegner; Hans-Günter Weeß; Petra Staubach
Journal:  Biology (Basel)       Date:  2022-03-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.